Repligen to Report Second Quarter 2020 Financial Results
WALTHAM, Mass., July 15, 2020 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its second […]
Organogenesis Holdings Inc. Reports Preliminary Revenue Results for Second Quarter 2020
CANTON, Mass., July 15, 2020 (GLOBE NEWSWIRE) — Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on […]
BridgeBio Pharma’s QED Therapeutics Doses First Child in Phase 2 Clinical Trial of the Investigational Medicine Infigratinib in Achondroplasia
SAN FRANCISCO, July 15, 2020 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) affiliate QED Therapeutics announced today that the […]
ICU Medical, Inc. Announces Time of Second Quarter 2020 Earnings Conference Call
SAN CLEMENTE, Calif., July 15, 2020 (GLOBE NEWSWIRE) — ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and […]
Monro, Inc. to Report First Quarter Fiscal 2021 Earnings on July 29, 2020
ROCHESTER, N.Y., July 15, 2020 (GLOBE NEWSWIRE) — Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and […]
Primoris Services Corporation Schedules Conference Call to Discuss 2020 Second Quarter Financial Results
DALLAS, July 15, 2020 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) announced today that […]
OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Second Quarter 2020
Preliminary Total Revenue for Q2 2020 was approximately $1.2 million dollarsBalance sheet strengthened significantly with $6.1 million cash raised in […]
QIWI Completes the Sale of its SOVEST Project
NICOSIA, Cyprus, July 15, 2020 (GLOBE NEWSWIRE) — QIWI plc (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”) today announced […]
Manuscript Describes How TLC’s Inhalable Liposomal Hydroxychloroquine May Provide Clinical Benefit and Serve as Potential Treatment for COVID-19
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan , July 15, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq: TLC, TWO: 4152), a […]
Orchard Therapeutics Announces Global License Agreements for Stable Cell Line Technology from GSK
BOSTON and LONDON, July 15, 2020 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced […]
